Correct, this is very different to Nox drug. This one is a monoclonal antibody the basic idea is it binds to Covid virus to stop it infecting cells. It’s not the first one, the FDA has already given emergency approval to two other antibodies for Covid in US. They seem to work in Covid based on results from trials….unlike the Nox drug which probably doesn’t. The idea of Nox drug is not to block virus but to damp down the excess immune response -except the data they’ve shown so far isn’t particularly good imo.
Ann: NOX and US Govt Peak Cancer Agency Announce Collaboration, page-21
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $137 | 1.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 110993 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 38999 | 2 |
View Market Depth
| Last trade - 10.06am 11/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |